IBM’s Watson cognitive computer will soon be helping Mayo Clinic enroll patients in clinical trials in an effort to increase the speed of new discoveries while offering patients more and better treatment possibilities. The collaboration will begin with research studies in cancer.

Mike Rhodin, senior vice president of the IBM Waston Group, announced the plans for the collaboration today at Mayo Clinic’s Transform 2014 Symposium in Rochester, Minn.

To read this article in full or to leave a comment, please click here

…